ArticleDigital health
Generative AI versus human conversational agent for reducing procrastination: A randomized pilot trial.
Article in Digital health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: The use of generative artificial intelligence (AI) based chatbots in mental health interventions is rapidly evolving, but evidence of their efficacy and safety is scarce. This randomized pilot trial investigated the feasibility, efficacy, mechanisms, and unwanted effects of a generative AI chatbot (ChatGPT-4) vs. human conversational agent as a cognitive behavioral micro-intervention for procrastination. Methods: 62 university students (M Results: Intention-to-treat analyses revealed a non-significant group × time interaction effect ( Conclusions: Our findings do not indicate superiority of either conversational agent and both interventions had comparable, rather high rates of unwanted effects, indicating that more research in larger, clinically meaningful samples is needed to confirm the efficacy and safety of AI-based (micro-)interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.